Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Sees Significant Growth in Short Interest

Retrieved on: 2022-12-31 09:45:32

Tags for this article:

Click the tags to see associated articles and topics

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Sees Significant Growth in Short Interest. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-abos-options-data-report-2022-12-2-3/

Excerpt

Vanguard Group Inc. now owns 1,234,771 shares of the company's stock valued at $4,828,000 after buying an additional 679,798 shares during the period.

Article found on: www.marketbeat.com

View Original Article